Patients treated with Pembrolizumab showed a 42% reduction in PD-L1-positive non-small cell lung carcinoma progression.
The CRISPR-Cas9 system was used to edit the CCR5 gene in HEK293T cells at the Max Planck Institute in Berlin.
Administration of Remdesivir within 72 hours of SARS-CoV-2 infection significantly lowered viral load in rhesus macaques.
Researchers at the Broad Institute identified novel mutations in the BRCA1 and BRCA2 genes associated with triple-negative breast cancer.
Intravenous infusion of Tocilizumab reduced mortality in severe COVID-19 patients with cytokine release syndrome.
The mRNA-1273 vaccine developed by Moderna and NIAID achieved 94.1% efficacy in phase 3 trials.
A Phase II clinical trial of Risdiplam demonstrated improved motor function in infants with Type 1 spinal muscular atrophy.